![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
FRESCO-2: Phase III study of fruquintinib in patients with mCRC (VJOncology) View |
![]() |
Dr. Cathy Eng Discusses FRESCO-2 Trial and Fruquintinib for Colorectal Cancer (DocWire) View |
![]() |
FRESCO-2: subgroup analysis of fruquintinib in mCRC with liver metastases (VJOncology) View |
![]() |
Tumor Profiling in Patients With mCRC (OncLive) View |
![]() |
Third-Line Therapy for Metastatic Colon Cancer (Targeted Oncology) View |
![]() |
mCRC: Factors to Consider for First-Line Therapy (Targeted Oncology) View |
![]() |
Expert report on immune checkpoint inhibitors for dMMR Colorectal Cancer (European Society for Medical Oncology (ESMO)) View |
![]() |
ESMO Expert Report on combination therapy in advanced prostate cancer @ ASCO GU 2022 (European Society for Medical Oncology (ESMO)) View |
![]() |
The Enterome Study - an Overview by Dr. Arvind Dasari (CRC MRD) View |
![]() |
Managing patients with CRC using ctDNA (VJOncology) View |